A NOTCH2 Mutation Causes Osteogenesis Imperfecta

NOTCH2突变导致成骨不完善

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Notch receptors play a critical role in cell fate decisions and in the regulation of bone remodeling, either directly or through the induction of their target genes, namely Hairy Enhancer of Split (HES) and Hes-related with YRPW motif (HEY). A 2 month old female child harboring a NOTCH2 pathogenic variant (e4006G>C) in exon 25 leading to a G1336R change in epidermal growth factor (EGF) repeat 34 presented with skeletal fragility and fractures. Never before has a mutation in Notch signaling been associated with osteogenesis imperfecta (OI). Whereas significant knowledge has been generated about the function of Notch receptors in the skeleton, little is known regarding mechanisms that control the activation of Notch and that are dependent on the interaction of its extracellular domain with Notch ligands. We created a Notch24006G>C mouse model (Notch2em1Ecan) that harbors a 4006G>C mutation in exon 25 of Notch2 and exhibits small and fragile bones replicating the genetic and functional outcomes of the human disorder. This reveals that a previously unrecognized mutation in the extracellular domain of NOTCH2 causes a skeletal syndrome; however, the mechanisms responsible for the skeletal manifestations are not established, and will be explored as part of the proposed research. Our specific aims are: Aim 1) To characterize the skeletal phenotype of Notch2em1Ecan mutants. Our goals are to establish the phenotype and cell lineage affected in Notch2 mutant mice and mechanisms responsible for the skeletal phenotype; Aim 2) To establish the mechanisms responsible for changes in Notch24006G>C mutant function. We will determine whether NOTCH2 mutants have altered affinity and binding to Notch ligands of the Jagged and Delta-like families and whether this results in changes in Notch activation and signaling in Notch2em1Ecan mutants. The goals of the proposed work are to understand novel functions of the NOTCH2 extracellular domain and the skeletal manifestations of diseases associated with a newly discovered NOTCH2 mutation.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ernesto Canalis其他文献

Ernesto Canalis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ernesto Canalis', 18)}}的其他基金

Mechanisms and Treatment of Hajdu Cheney Syndrome
Hajdu Cheney 综合症的机制和治疗
  • 批准号:
    10655476
  • 财政年份:
    2021
  • 资助金额:
    $ 18.22万
  • 项目类别:
Mechanisms and Treatment of Hajdu Cheney Syndrome
Hajdu Cheney 综合症的机制和治疗
  • 批准号:
    10437901
  • 财政年份:
    2021
  • 资助金额:
    $ 18.22万
  • 项目类别:
Mechanisms and Treatment of Hajdu Cheney Syndrome
Hajdu Cheney 综合症的机制和治疗
  • 批准号:
    10263404
  • 财政年份:
    2021
  • 资助金额:
    $ 18.22万
  • 项目类别:
Targeting the Notch3 Mutation to Cure Lehman Syndrome
针对 Notch3 突变来治愈雷曼综合症
  • 批准号:
    10017652
  • 财政年份:
    2019
  • 资助金额:
    $ 18.22万
  • 项目类别:
Targeting the Notch3 Mutation to Cure Lehman Syndrome
针对 Notch3 突变来治愈雷曼综合症
  • 批准号:
    10684552
  • 财政年份:
    2019
  • 资助金额:
    $ 18.22万
  • 项目类别:
Targeting the Notch3 Mutation to Cure Lehman Syndrome
针对 Notch3 突变来治愈雷曼综合症
  • 批准号:
    9901099
  • 财政年份:
    2019
  • 资助金额:
    $ 18.22万
  • 项目类别:
The Skeleton of Lateral Meningocele Syndrome
侧脑膜膨出综合征的骨骼
  • 批准号:
    10528430
  • 财政年份:
    2018
  • 资助金额:
    $ 18.22万
  • 项目类别:
The Skeleton of Lateral Meningocele Syndrome
侧脑膜膨出综合征的骨骼
  • 批准号:
    9899095
  • 财政年份:
    2018
  • 资助金额:
    $ 18.22万
  • 项目类别:
Role of NFAT in the Skeleton
NFAT 在骨骼中的作用
  • 批准号:
    9053006
  • 财政年份:
    2015
  • 资助金额:
    $ 18.22万
  • 项目类别:
Role of NFAT in the Skeleton
NFAT 在骨骼中的作用
  • 批准号:
    9146275
  • 财政年份:
    2015
  • 资助金额:
    $ 18.22万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 18.22万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 18.22万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 18.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了